Area of research
Critical Care and Intensive Care Medicine · Cancer Research
Research interest
Research interests include Intensive Care Unit Cognitive Disorders, NF-κB Signaling Pathways, Pharmacogenetics and Drug Metabolism, and Computational Drug Discovery Methods.
Proteomic Analysis Identifies Novel Plasma Biomarkers in Patients With Vestibular Schwannoma
Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction–associated steatohepatitis
DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway
Dietary inflammatory and insulinemic potential, risk of hepatocellular carcinoma, and chronic liver disease mortality
High-Multiplex Aptamer-Based Serum Proteomics to Identify Candidate Serum Biomarkers of Oral Squamous Cell Carcinoma
Emerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Review
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Inflammatory metabolic profile of South African patients with prostate cancer
Placenta accreta spectrum: biomarker discovery using plasma proteomics
Exosome swarms eliminate airway pathogens and provide passive epithelial immunoprotection through nitric oxide
Detecting Microbial Dysbiosis Associated with Pediatric Crohn Disease Despite the High Variability of the Gut Microbiota
Relaxation Response Induces Temporal Transcriptome Changes in Energy Metabolism, Insulin Secretion and Inflammatory Pathways
Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4
A metabolic prosurvival role for PML in breast cancer
P02.117. Genomic expression changes underlying mind-body practices